MARKET

BMRA

BMRA

Biomerica
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.980
-0.160
-3.86%
Opening 11:37 06/24 EDT
OPEN
4.130
PREV CLOSE
4.140
HIGH
4.190
LOW
3.920
VOLUME
177.32K
TURNOVER
--
52 WEEK HIGH
12.75
52 WEEK LOW
3.300
MARKET CAP
48.96M
P/E (TTM)
-8.5518
1D
5D
1M
3M
1Y
5Y
Biomerica inks exclusive distribution agreement in Canada for Helicobacter pylori test
Biomerica (BMRA) has signed an exclusive five-year distribution agreement with a Canadian partner for the distribution and marketing of its new Helicobacter pylori test, called hp+detect.The hp+detect product has been developed for
Seekingalpha · 3h ago
BRIEF-Biomerica Signs Exclusive Distribution Agreement In Canada For Its New And Proprietary Helicobacter Pylori (H. Pylori) Test, Hp+Detect™
reuters.com · 3h ago
Biomerica Signs Exclusive Distribution Agreement in Canada for its New and Proprietary Helicobacter Pylori (H. pylori) Test, hp+detect(TM)
Biomerica Inc. (NASDAQ: BMRA) today announced that it has signed an exclusive five-year distribution agreement with a Canadian partner for the distribution and marketing of Biomerica's new and proprietary Helicobacter pylori test, called hp+detect(TM). The...
GlobeNewswire · 3h ago
50+ Companies to Present at the Access to Giving Virtual Investor Conference - July 13th - 15th, 2021
RALEIGH, NC / ACCESSWIRE / June 23, 2021 / Access to Giving - an investor conference themed around investor education and advocacy is set for July 13-15, 2021. There will be 50+ companies conducting virtual presentations as well as private meetings with qu...
ACCESSWIRE · 16h ago
Biomerica gets notice of allowance from Mexican Patent Office
Biomerica (BMRA) announces that the Mexican Patent Office has issued a notice of allowance for the company's patent application pertaining to its InFoods technology platform, which is used to treat patients with
Seekingalpha · 06/15 12:45
BRIEF-Biomerica Receives Notice Of Allowance From Mexican Patent Office
reuters.com · 06/15 12:20
Biomerica Receives Notice Of Allowance From Mexican Patent Office For Irritable Bowel Syndrome Food Sensitivity Testing & Treatment
Biomerica, Inc. (NASDAQ:BMRA) today announced that the Mexican Patent Office has issued a notice of allowance for Biomerica's patent application pertaining to the Company's InFoods® technology platform
Benzinga · 06/15 12:20
64 Biggest Movers From Friday
Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share.
Benzinga · 06/14 09:04
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BMRA. Analyze the recent business situations of Biomerica through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average BMRA stock price target is 10.88 with a high estimate of 13.00 and a low estimate of 9.50.
EPS
Institutional Holdings
Institutions: 45
Institutional Holdings: 3.74M
% Owned: 30.43%
Shares Outstanding: 12.30M
TypeInstitutionsShares
Increased
9
655.46K
New
8
298.40K
Decreased
8
147.22K
Sold Out
5
58.64K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.59%
Healthcare Equipment & Supplies
+0.27%
Key Executives
Chairman/Director/Chief Executive Officer
Zackary Irani
Vice Chairman/Secretary/Lead Director/Director/Independent Director
Allen Barbieri
Chief Financial Officer
Steve Sloan
Chief Financial Officer
Steven Sloan
Independent Director
Francis Cano
Independent Director
Catherine Coste
Independent Director
Jane Emerson
Independent Director
Cathy Coste
Independent Director
Mark Sirgo
No Data
About BMRA
Biomerica, Inc. is a biomedical company, which develops, manufactures, and markets medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The medical diagnostic products are sold in two markets: clinical laboratories and point of care. The diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications, by measuring or detecting the existence and/or level of specific bacteria, hormones, antibodies, antigens or other substances, which may exist in a patient’s body, stools, or blood, often in extremely small concentrations. Biomerica has developed a diagnostic guided therapy that is designed to allow physicians to identify patient-specific foods, that when removed from the diet, may alleviate or improve an individual's symptoms of Irritable Bowel Syndrome (IBS). This product is called InFoods IBS.

Webull offers kinds of Biomerica, Inc. stock information, including NASDAQ:BMRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMRA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BMRA stock methods without spending real money on the virtual paper trading platform.